Aucubin protects mouse cochlear hair cells from cisplatin-induced ototoxicity via activation of the PI3K/AKT/STAT3 pathway

Biochem Pharmacol. 2023 Mar:209:115440. doi: 10.1016/j.bcp.2023.115440. Epub 2023 Jan 30.

Abstract

Cisplatin is commonly used to treat cancers and is associated with a significant risk of irreversible sensorineural hearing loss. However, no effective preventive strategies are available for cisplatin-induced HL. Therefore, significant efforts have been made to discover new drugs protecting cochlear hair cells from cisplatin-induced damage. We found that a new phytochemical, aucubin, attenuated cisplatin-induced apoptosis, the production of reactive oxygen species, and mitochondrial dysfunction in House Ear Institute Organ of Corti 1 cells and cochlear hair cells. Moreover, aucubin attenuated cisplatin-induced sensorineural hearing loss and hair cells loss in vivo. Furthermore, RNA sequencing analysis revealed that the otoprotective effects of aucubin were mainly mediated by increased STAT3 phosphorylation via the PI3K/AKT pathway. Inhibition of the STAT3 signaling pathway with the inhibitor S3I-201 or siRNA disrupted the protective effects of aucubin on cisplatin-induced apoptosis. In conclusion, we identified an otoprotective effect of aucubin. Therefore, aucubin could be used to prevent cisplatin-induced ototoxicity.

Keywords: Aucubin; Cisplatin; Ototoxicity; PI3K/AKT; p-STAT3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents* / pharmacology
  • Apoptosis
  • Cisplatin / pharmacology
  • Cochlea / metabolism
  • Hair Cells, Auditory
  • Hearing Loss* / chemically induced
  • Hearing Loss* / drug therapy
  • Hearing Loss* / prevention & control
  • Hearing Loss, Sensorineural* / drug therapy
  • Hearing Loss, Sensorineural* / metabolism
  • Mice
  • Ototoxicity* / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Reactive Oxygen Species / metabolism

Substances

  • Cisplatin
  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases
  • aucubin
  • Reactive Oxygen Species
  • Antineoplastic Agents